Invivyd Inc
(NASDAQ:IVVD)
$2.28
At close: Feb 2
$2.28
PreMarket: 4:51PM EDT
Day Range- - -52 Wk Range1.420 - 4.890Open / Close- / -Float / Outstanding17.528M / 108.982M
Vol / Avg.0 / 307.811KMkt Cap248.480MP/E-50d Avg. Price1.960
Div / Yield (Forward)- / -%Payout Ratio-Total Float17.528MEPS-0.080

Invivyd Stock (NASDAQ:IVVD), Quotes and News Summary

Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.420 - 4.890Open / Close- / -Float / Outstanding17.528M / 108.982M
Vol / Avg.0 / 307.811KMkt Cap248.480MP/E-50d Avg. Price1.960
Div / Yield (Forward)- / -%Payout Ratio-Total Float17.528MEPS-0.080
Newsfile - 9 hours ago
Newsfile - 1 day ago
Sector: Health Care.Industry: Biotechnology
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-29
REV
Q3 2022Est.ActualSurprise
EPS-0.490-0.420 0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Invivyd (IVVD) stock?

A

You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Invivyd's (IVVD) competitors?

Q

What is the target price for Invivyd (IVVD) stock?

A

The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Invivyd (IVVD)?

A

The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Invivyd (IVVD) pay a dividend?

A

There are no upcoming dividends for Invivyd.

Q

When is Invivyd (NASDAQ:IVVD) reporting earnings?

A

Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.

Q

Is Invivyd (IVVD) going to split?

A

There is no upcoming split for Invivyd.

Q

What sector and industry does Invivyd (IVVD) operate in?

A

Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Invivyd Stock (NASDAQ:IVVD), Quotes and News Summary

Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.420 - 4.890Open / Close- / -Float / Outstanding17.528M / 108.982M
Vol / Avg.0 / 307.811KMkt Cap248.480MP/E-50d Avg. Price1.960
Div / Yield (Forward)- / -%Payout Ratio-Total Float17.528MEPS-0.080
Newsfile - 9 hours ago
Newsfile - 1 day ago
Sector: Health Care.Industry: Biotechnology
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-29
REV
Q3 2022Est.ActualSurprise
EPS-0.490-0.420 0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Invivyd (IVVD) stock?

A

You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Invivyd's (IVVD) competitors?

Q

What is the target price for Invivyd (IVVD) stock?

A

The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Invivyd (IVVD)?

A

The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Invivyd (IVVD) pay a dividend?

A

There are no upcoming dividends for Invivyd.

Q

When is Invivyd (NASDAQ:IVVD) reporting earnings?

A

Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.

Q

Is Invivyd (IVVD) going to split?

A

There is no upcoming split for Invivyd.

Q

What sector and industry does Invivyd (IVVD) operate in?

A

Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Invivyd Stock (NASDAQ:IVVD), Quotes and News Summary

Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.420 - 4.890Open / Close- / -Float / Outstanding17.528M / 108.982M
Vol / Avg.0 / 307.811KMkt Cap248.480MP/E-50d Avg. Price1.960
Div / Yield (Forward)- / -%Payout Ratio-Total Float17.528MEPS-0.080
Newsfile - 9 hours ago
Newsfile - 1 day ago
Sector: Health Care.Industry: Biotechnology
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-29
REV
Q3 2022Est.ActualSurprise
EPS-0.490-0.420 0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Invivyd (IVVD) stock?

A

You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Invivyd's (IVVD) competitors?

Q

What is the target price for Invivyd (IVVD) stock?

A

The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Invivyd (IVVD)?

A

The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Invivyd (IVVD) pay a dividend?

A

There are no upcoming dividends for Invivyd.

Q

When is Invivyd (NASDAQ:IVVD) reporting earnings?

A

Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.

Q

Is Invivyd (IVVD) going to split?

A

There is no upcoming split for Invivyd.

Q

What sector and industry does Invivyd (IVVD) operate in?

A

Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Invivyd Stock (NASDAQ:IVVD), Quotes and News Summary

Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.420 - 4.890Open / Close- / -Float / Outstanding17.528M / 108.982M
Vol / Avg.0 / 307.811KMkt Cap248.480MP/E-50d Avg. Price1.960
Div / Yield (Forward)- / -%Payout Ratio-Total Float17.528MEPS-0.080
Newsfile - 9 hours ago
Newsfile - 1 day ago
Sector: Health Care.Industry: Biotechnology
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-29
REV
Q3 2022Est.ActualSurprise
EPS-0.490-0.420 0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Invivyd (IVVD) stock?

A

You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Invivyd's (IVVD) competitors?

Q

What is the target price for Invivyd (IVVD) stock?

A

The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Invivyd (IVVD)?

A

The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Invivyd (IVVD) pay a dividend?

A

There are no upcoming dividends for Invivyd.

Q

When is Invivyd (NASDAQ:IVVD) reporting earnings?

A

Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.

Q

Is Invivyd (IVVD) going to split?

A

There is no upcoming split for Invivyd.

Q

What sector and industry does Invivyd (IVVD) operate in?

A

Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Invivyd Stock (NASDAQ:IVVD), Quotes and News Summary

Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.420 - 4.890Open / Close- / -Float / Outstanding17.528M / 108.982M
Vol / Avg.0 / 307.811KMkt Cap248.480MP/E-50d Avg. Price1.960
Div / Yield (Forward)- / -%Payout Ratio-Total Float17.528MEPS-0.080
Newsfile - 9 hours ago
Newsfile - 1 day ago
Sector: Health Care.Industry: Biotechnology
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-29
REV
Q3 2022Est.ActualSurprise
EPS-0.490-0.420 0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Invivyd (IVVD) stock?

A

You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Invivyd's (IVVD) competitors?

Q

What is the target price for Invivyd (IVVD) stock?

A

The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Invivyd (IVVD)?

A

The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Invivyd (IVVD) pay a dividend?

A

There are no upcoming dividends for Invivyd.

Q

When is Invivyd (NASDAQ:IVVD) reporting earnings?

A

Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.

Q

Is Invivyd (IVVD) going to split?

A

There is no upcoming split for Invivyd.

Q

What sector and industry does Invivyd (IVVD) operate in?

A

Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Invivyd Stock (NASDAQ:IVVD), Quotes and News Summary

Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.420 - 4.890Open / Close- / -Float / Outstanding17.528M / 108.982M
Vol / Avg.0 / 307.811KMkt Cap248.480MP/E-50d Avg. Price1.960
Div / Yield (Forward)- / -%Payout Ratio-Total Float17.528MEPS-0.080
Newsfile - 9 hours ago
Newsfile - 1 day ago
Sector: Health Care.Industry: Biotechnology
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-29
REV
Q3 2022Est.ActualSurprise
EPS-0.490-0.420 0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Invivyd (IVVD) stock?

A

You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Invivyd's (IVVD) competitors?

Q

What is the target price for Invivyd (IVVD) stock?

A

The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Invivyd (IVVD)?

A

The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Invivyd (IVVD) pay a dividend?

A

There are no upcoming dividends for Invivyd.

Q

When is Invivyd (NASDAQ:IVVD) reporting earnings?

A

Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.

Q

Is Invivyd (IVVD) going to split?

A

There is no upcoming split for Invivyd.

Q

What sector and industry does Invivyd (IVVD) operate in?

A

Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Invivyd Stock (NASDAQ:IVVD), Quotes and News Summary

Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.420 - 4.890Open / Close- / -Float / Outstanding17.528M / 108.982M
Vol / Avg.0 / 307.811KMkt Cap248.480MP/E-50d Avg. Price1.960
Div / Yield (Forward)- / -%Payout Ratio-Total Float17.528MEPS-0.080
Newsfile - 9 hours ago
Newsfile - 1 day ago
Sector: Health Care.Industry: Biotechnology
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-29
REV
Q3 2022Est.ActualSurprise
EPS-0.490-0.420 0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Invivyd (IVVD) stock?

A

You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Invivyd's (IVVD) competitors?

Q

What is the target price for Invivyd (IVVD) stock?

A

The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Invivyd (IVVD)?

A

The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Invivyd (IVVD) pay a dividend?

A

There are no upcoming dividends for Invivyd.

Q

When is Invivyd (NASDAQ:IVVD) reporting earnings?

A

Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.

Q

Is Invivyd (IVVD) going to split?

A

There is no upcoming split for Invivyd.

Q

What sector and industry does Invivyd (IVVD) operate in?

A

Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Invivyd Stock (NASDAQ:IVVD), Quotes and News Summary

Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.420 - 4.890Open / Close- / -Float / Outstanding17.528M / 108.982M
Vol / Avg.0 / 307.811KMkt Cap248.480MP/E-50d Avg. Price1.960
Div / Yield (Forward)- / -%Payout Ratio-Total Float17.528MEPS-0.080
Newsfile - 9 hours ago
Newsfile - 1 day ago
Sector: Health Care.Industry: Biotechnology
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-29
REV
Q3 2022Est.ActualSurprise
EPS-0.490-0.420 0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Invivyd (IVVD) stock?

A

You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Invivyd's (IVVD) competitors?

Q

What is the target price for Invivyd (IVVD) stock?

A

The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Invivyd (IVVD)?

A

The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Invivyd (IVVD) pay a dividend?

A

There are no upcoming dividends for Invivyd.

Q

When is Invivyd (NASDAQ:IVVD) reporting earnings?

A

Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.

Q

Is Invivyd (IVVD) going to split?

A

There is no upcoming split for Invivyd.

Q

What sector and industry does Invivyd (IVVD) operate in?

A

Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.